Activest Wealth Management
UTHR icon

Activest Wealth Management’s United Therapeutics UTHR Stock Holding History

Activest Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-44
Closed -$23.8K – 1362
2026
Q2 		$23.8K Sell
44
-7
-14% -$3.94K ﹤0.01% 410
2026
Q1 		$30.2K Sell
51
-9
-15% -$4.48K 0.01% 425
2025
Q4 		$29.2K Buy
60
+56
+1,400% +$26.1K 0.01% 419
2025
Q3 		$1.68K Hold
4
– – ﹤0.01% 803
2025
Q2 		$1.15K Buy
+4
New +$1.2K ﹤0.01% 760

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Seizert Capital Partners
Seizert Capital Partners Birmingham, Michigan $2.3B AUM 16.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Activest Wealth Management's UTHR Position: Q3 2026 in Review

Activest Wealth Management sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 44 shares — an estimated $23.8K sold.

Activest Wealth Management first reported a position in UTHR in Q2 2025 and held it in 5 quarters. The position peaked at $30.2K in Q1 2026. 261 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Activest Wealth Management reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Activest Wealth Management sold 44 United Therapeutics shares in Q3 2026, an estimated $23.8K.
  • Activest Wealth Management first reported a position in United Therapeutics in Q2 2025 and held it in 5 quarters.
  • Activest Wealth Management's United Therapeutics position peaked at $30.2K in Q1 2026.
  • 261 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.